FT Pharma Leadership Forum
The pharmaceutical industry is navigating a perfect storm of challenges that are profoundly reshaping its commercial landscape and impacting future growth prospects. Intensifying pricing pressures are forcing manufacturers to justify product value with hard evidence. Changes in national healthcare systems and the growing role of health technology assessment in healthcare decision making further add to commercialisation complexity. Simultaneously, R&D costs continue to increase, creating a significant financial burden on companies. This confluence of external pressures is forcing a re-evaluation of every aspect of the business.
In this context, the accelerating adoption of Artificial Intelligence (AI), along with advances in agentic AI, presents both an opportunity and a new set of complexities. AI promises to streamline drug discovery, optimise clinical trials, and personalise patient engagement, potentially reducing costs and accelerating market access. However, it also demands significant investment in new technologies, talent, and data infrastructure. For those responsible for P&L, and digital leaders, it will mean re-evaluating strategic investments in R&D and digital infrastructure, whilst overseeing a workforce and cultural transformation that requires re-skilling of teams, enabling them to navigate complex digital ecosystems. Brand and commercial teams will need to redesign personalised, integrated customer journeys that span digital and in-person touchpoints, demanding a deep understanding of patient and physician preferences.
This event, held in partnership with Indegene, will bring together financial, commercial and digital leaders from pharmaceutical and biotechnology companies to share insights on how they are adjusting to the new commercial realities of pharma and overcoming complexities of enterprise-wide adoption and implementation of AI to enable innovation at scale, drive growth, and shape future business models.
Key Discussion Points
Scaling and Operationalising AI in Pharma
How can pharma companies move beyond isolated AI pilots to embed AI as a core capability across the enterprise?
Agentic AI and the Future of Innovation
What safeguards and frameworks are needed to ensure trust in agentic AI systems making high-stakes decisions in healthcare?
AI Operating Models and Strategic Alignment
Which AI operating models are best positioned to balance innovation speed with long-term strategic scalability in pharma?
Why Attend?
Understand
how leading pharma companies are scaling AI, overcoming operational challenges, and measuring real-world impact across the value chain.
Connect
with industry pioneers and AI leaders who are shaping the future of pharmaceutical innovation and organisational transformation.
Discover
new models, technologies, and strategies that are redefining how pharma delivers value through AI.
We’re Here To Help
© Financial Times Live
FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice
